BIO-TECHNE
R D Systems CTPI 2 50 mg
A Tocris product, part of R&D Systems. Selective mitochondrial citrate transporter (SLC25A1) inhibitor CTPI 2 is a selective mitochondrial citrate transporter (SLC25A1) inhibitor with a KD of 3.
A Tocris product, part of R&D Systems. Selective mitochondrial citrate transporter (SLC25A1) inhibitor CTPI 2 is a selective mitochondrial citrate transporter (SLC25A1) inhibitor with a KD of 3.5 M. CTPI 2 inhibits the proliferation of H1299 cells in a SLC25A1-dependent manner. It also re-sensitizes T1, T2, and T4 cells to Cisplatin (Cat. No. 2251). CTPI 2 inhibits tumor growth in in vivo models of non-small cell lung cancer (NSCLC). In high-fat diet fed mice CTPI 2 regulates glycolysis, prevents steatohepatitis and normalizes glucose tolerance and insulin sensitivity. CTPI 2 influences the inflammatory pathway by inhibiting IL-6 and TNF production and M1 macrophage polarization.
- UPC:
- 42201503
- Weight:
- 1.00 Ounces
- HazmatClass:
- No
- Quantity:
- 1
- Unit of Measurement:
- EA
- WeightUOM:
- LB
- MPN:
- 7794/50



